Performance Under Pressure
Product safety and drug development
When golf champions win, it's often in the spotlight, watched carefully by competitors, fans and television audiences potentially totaling millions of people. The stress is extraordinary. Likewise, pharmaceutical, biotech and medical device companies are closely scrutinized by regulators, investors, the medical community, patients and the public. These businesses have the potential to change lives, but do so under extraordinary pressure.
Deloitte works with life sciences companies to develop practical, executable strategies for addressing critical issues such as pharmacovigilance (PV) execution and drug safety compliance, document management, adverse events processing and product safety monitoring. Our practitioners have significant experience across a broad cross-section of life sciences organizations addressing PV. Deloitte is recognized as world class and a thought leader in the life sciences industry.
As used in this document, “Deloitte” means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.